LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Birmingham Hospital Opens New Automated Blood Sciences Laboratory

By LabMedica International staff writers
Posted on 14 Jun 2012
Image: The new Queen Elizabeth Hospital Birmingham’s laboratory uses state-of-the-art Roche analytical platforms to reduce turnaround times (Photo courtesy of the University Hospitals Birmingham NHS Foundation Trust).
Image: The new Queen Elizabeth Hospital Birmingham’s laboratory uses state-of-the-art Roche analytical platforms to reduce turnaround times (Photo courtesy of the University Hospitals Birmingham NHS Foundation Trust).
A new automated blood sciences laboratory in a Birmingham hospital has an automated track system that simplifies laboratory processes and improves turnaround times.

The University Hospitals Birmingham NHS Foundation Trust has opened an automated blood sciences laboratory at the new Queen Elizabeth Hospital in Birmingham (Birmingham, United Kingdom). Equipped with state-of-the-art Roche (Burgess Hill, United Kingdom) analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.

The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular preanalytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.

The cobas 8000 modular analyzer series is designed for high workload laboratories and can cover a range of 3 up to 15 million tests per year. With a peak throughput of 8,400 tests per hour and many innovative design elements to allow unrestricted sample flow and intelligent sample routing, the cobas 8000 modular analyzer series significantly improves sample turnaround time and efficiently addresses peak demands. High speed, intelligent sample dynamics, and workflow improvements further enhance productivity and efficiency for high workload laboratories.

“The fully automated track system with pre- and post-analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explained laboratory manager, Chris Gaskin. “The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more lean in our processes and is much more TAT efficient for our high workloads.”

The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital,” Chris Gaskin concluded. “When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on Laboratory Information Management System (LIMS) and then sort the samples into appropriate racks, depending on their destination. This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”

Related Links:
Queen Elizabeth Hospital in Birmingham
Roche

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more